{
    "2021-11-24": [
        [
            {
                "time": "2021-11-24",
                "original_text": "复星医药参设多个基金加强布局大健康产业 阿里健康中期亏损2.32亿元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "投资基金",
                        "大健康产业",
                        "阿里健康",
                        "中期亏损"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "大健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-24",
                "original_text": "复星医药：设立安吉及徐州投资基金，计划募集资金均为5亿元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "安吉基金",
                        "徐州基金",
                        "募集资金"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "大健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-24",
                "original_text": "复星医药：成立合伙企业",
                "features": {
                    "keywords": [
                        "复星医药",
                        "合伙企业"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-24",
                "original_text": "复星医药：董事会建议销售交易年度上限调整为7.5亿元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "销售交易",
                        "年度上限",
                        "调整"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-24",
                "original_text": "复星医药（02196）：‘18复药02’将于11月30日付息",
                "features": {
                    "keywords": [
                        "复星医药",
                        "债券付息",
                        "18复药02"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-24",
                "original_text": "复星医药（02196）及控股子公司拟与宁波星曜共同投资设立股权投资基金大连复健",
                "features": {
                    "keywords": [
                        "复星医药",
                        "股权投资基金",
                        "大连复健"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "大健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-24",
                "original_text": "中山公用：股东复星集团拟减持不超6%公司股份",
                "features": {
                    "keywords": [
                        "中山公用",
                        "复星集团",
                        "减持"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-24",
                "original_text": "为持续加强对前沿创新药研发项目的早期介入 复星医药（600196.SH）拟参设基金",
                "features": {
                    "keywords": [
                        "复星医药",
                        "创新药",
                        "早期介入",
                        "基金"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "创新药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}